RPL17 and cancer: When PD-L1 interacts with PD-1 on T cells, the intracellular protein tyrosine phosphatase SHP-2 activates the downstream signal pathway of PD-1, which impedes T-cell activation, that prevents T cells from killing cancer cells by preventing the proliferation and function of T-cells (3, 4).